New Perspectives On Metastatic Brain Cancer
The dispersion of cancer cells from initial tumors to the brain's tissue results in metastatic brain disease that produces severe complications of health. Modern scientific studies stress that the tumor microenvironment creates conditions that facilitate immune evasion during metastasis. The development of molecular profiling methods and targeted therapy products based on immune checkpoint inhibitors unlock fresh therapeutic options that help doctors deliver better patient results through precise treatment of metastatic brain tumor molecular and genetic variations.
